News / Asia

    Health Care Bribery in China: Why it Worries Global Drug Makers

    A Chinese national flag flutters in front of a GlaxoSmithKline (GSK) office building in Shanghai, July 12, 2013.
    A Chinese national flag flutters in front of a GlaxoSmithKline (GSK) office building in Shanghai, July 12, 2013.
    A high-profile Chinese investigation of alleged bribery at Britain-based drug giant GlaxoSmithKline is drawing attention to the growing presence of foreign pharmaceutical companies in China's booming health care market.

    The recent arrest of four Chinese GSK executives implicated in the scandal also highlights the challenges facing the foreign drug makers as they deal with deep-rooted corruption in Chinese health care and Beijing's new efforts to crack down on it.

    Chinese authorities announced the arrests on Monday, saying the executives are suspected of bribing doctors, hospitals and government officials to boost sales and prices of GSK products in China.

    China also has placed a travel ban on the British finance director of GSK's China division, Steve Nechelput, preventing him from leaving the country.

    GSK confirmed the ban on Thursday, but said Nechelput has not been questioned or detained. It also has pledged to cooperate with Chinese authorities in combating corruption.

    GSK is one of 38 multinational drug companies with research and development capabilities operating in China. An organization representing those firms, the R&D-Based Pharmaceutical Association Committee (RDPAC)), said they invested $3 billion in China from 2006 to 2010.

    Growth potential

    Victoria Lai, a New York-based China analyst at the Economist Intelligence Unit, told VOA that foreign drug companies see China as a crucial market to grow their business as sales slow elsewhere.

    "The pharmaceutical market in China is still relatively undeveloped," she said. "The size of the market is only around 17 percent of the size of the U.S. market (by value), even though the [Chinese] population is much bigger."

    The EIU says pharmaceutical sales in China reached $69 billion in 2012. It predicts those sales will more than double to $166 billion in 2017.

    "By then [China] will have surpassed Japan to be the world's second biggest pharmaceutical market," Lai said. "So that is something that foreign drug makers really do not want to miss out on."

    Several factors have contributed to surging purchases of pharmaceuticals in China.

    "Health care coverage in the country has been expanding rapidly and incomes are rising rapidly as well," Lai said. "As China grows richer, they are experiencing more lifestyle changes leading to different diseases. For example, with changing diets, more people are getting what we would call rich world diseases, like diabetes."

    Besides selling drugs in China, multinational companies also have increased research and manufacturing operations there.

    Deepening investment

    RDPAC says its members spent about $1 billion to build 22 R&D facilities in China from 2006 to 2010. It says 70 percent of member companies also have established Chinese manufacturing plants.

    Lai said foreign companies need the R&D facilities to run clinical trials of their medications before Chinese regulators will approve them. She said Chinese officials also have been encouraging the companies to manufacture the drugs inside China.

    "Part of this is because they want to boost various sectors of their economy, and biotech and pharmaceuticals manufacturing is very attractive, because it counts as higher value and can generate quite a bit of output and tax income in the future," she said.

    The expansion of foreign drug makers in China also has increased their risk of involvement in corrupt practices that have plagued Chinese hospitals and clinics for decades.

    Bribery risks

    American firms Pfizer and Eli Lilly paid tens of millions of dollars to the U.S. government last year to settle charges of corruption in foreign markets, including China.

    Wang Fangqing, a Shanghai-based health reporter for SCRIP Intelligence, told VOA it is common for drug makers, foreign and local, to pay bribes to ensure that drugs are distributed in hospitals and prescribed to patients. "GSK is definitely not alone," she said.

    Many Chinese medical workers accept bribes and sell drugs at artificially high prices to supplement low incomes and weak state funding for health care. Such practices are so typical that Chinese people often refer to them by the phrase Yi Yao Yang Yi, or "feeding hospitals by selling drugs."

    Wang said China launched health care reform almost a decade ago to change that system. "But little has changed," she said.

    EIU analyst Lai blamed the lack of progress on poor enforcement of rules against corrupt behaviors.

    "Those [drug companies] that do not adopt these practices find it really hard to compete with those that do," Lai said. "They see themselves as being left behind in terms of being prescribed to patients. This is the case not just for foreign drug makers but for local drug makers as well."

    The Chinese government's investigation of GSK and other recent measures indicate that Beijing is getting tougher.

    Crackdown intensifies

    The State Food and Drug Administration said Wednesday it will stage a six-month operation against drug industry misconduct.

    China's National Development and Reform Commission also recently launched an investigation of prices charged by 60 local and international drug makers, including units of GSK, U.S.-based Merck and Japan's Astellas Pharma.

    Belgium-based company UCB said Thursday Chinese regulators have visited its offices and those of other drug makers in recent days.

    Beijing is under pressure to act in response to long-running public anger about the high prices of medications not covered by state health insurance plans.

    But Lai said it is too early to tell if China is serious about including domestic companies in the crackdown.

    "It could be another example of Chinese investigators targeting a high profile Western company just to make a point. There is a risk that it is only targeting foreign companies to give local drug makers a bit of a leg up [boost]."

    In a commentary published Thursday, Chinese state news agency Xinhua denied any attempt to "sacrifice international firms to give domestic companies unfair advantages."

    Xinhua said Beijing is "firmly opposed to commercial bribery in all forms." It vowed that malpractice by "any enterprise -- Chinese, foreign or jointly-funded -- shall be punished."

    Michael Lipin

    Michael covers international news for VOA on the web, radio and TV, specializing in the Middle East and East Asia Pacific. Follow him on Twitter @Michael_Lipin

    You May Like

    Video Somali, AU Forces Face Resurgent Al-Shabab

    Somalia’s Western backers frustrated over country’s slow progress in establishing its armed forces to bring security after 25 years of chaos

    Israel Makes Push for Gaza Strip Recovery

    After years of economic blockade and attempts to disable Hamas, Israeli leaders eventually realized that Hamas’ downfall could lead to chaos or the rise of a more radical Jihadist group

    Slump in Chinese Tourists Hitting Hong Kong Retail

    Mainland Chinese account for up to three-quarters of visitors to Hong Kong, but that number is falling, and shopping centers are struggling to 'shift gears' and maintain sales

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Somali, African Union Forces Face Resurgent Al-Shababi
    X
    Henry Ridgwell
    April 28, 2016 4:20 PM
    The Islamic State terror group claimed its first attack in Somalia earlier this week, though the claim has not been verified by forces on the ground. Meanwhile, al-Shabab militants have stepped up their attacks as Somalia prepares for elections later this year. Henry Ridgwell reports there are growing frustrations among Somalia’s Western backers over the country’s slow progress in forming its own armed forces to establish security after 25 years of chaos.
    Video

    Video Somali, African Union Forces Face Resurgent Al-Shabab

    The Islamic State terror group claimed its first attack in Somalia earlier this week, though the claim has not been verified by forces on the ground. Meanwhile, al-Shabab militants have stepped up their attacks as Somalia prepares for elections later this year. Henry Ridgwell reports there are growing frustrations among Somalia’s Western backers over the country’s slow progress in forming its own armed forces to establish security after 25 years of chaos.
    Video

    Video Bangladesh Targeted Killings Spark Wave of Fear

    People in Bangladesh’s capital are expressing deep concern over the brutal attacks that have killed secular blogger, and most recently a gay rights activist and an employee of the U.S. embassy. Xulhaz Mannan, an embassy protocol officer and the editor of the country’s only gay and transgender magazine Roopban; and his friend Mehboob Rabbi Tanoy, a gay rights activist, were hacked to death by five attackers in Mannan’s Dhaka home earlier this month.
    Video

    Video Documentary Tells Tale of Chernobyl Returnees

    Ukraine this week is marking the 30th anniversary of the world's worst nuclear accident, at the Chernobyl nuclear power plant. Soviet officials at first said little about the accident, but later evacuated a 2,600-square-kilometer "exclusion zone." Some people, though, came back. American directors Holly Morris and Anne Bogart created a documentary about this faithful and brave community. VOA's Tetiana Kharchenko reports from New York on "The Babushkas of Chernobyl." Carol Pearson narrates.
    Video

    Video Nigerians Feel Bite of Buhari Economic Policy

    Despite the global drop in the price of oil, Nigerian President Muhammadu Buhari has refused to allow the country's currency to devalue, leading to a shortage of foreign exchange. Chris Stein reports from Lagos businessmen and consumers are feeling the impact as the country deals with a severe fuel shortage.
    Video

    Video  Return to the Wild

    There’s a growing trend in the United States to let old or underused golf courses revert back to nature. But as Erika Celeste reports from one parcel in Grafton, Ohio, converting 39 hectares of land back to green space is a lot more complicated than just not mowing the fairway.
    Video

    Video West Urges Unity in Libya as Migrant Numbers Soar

    The Italian government says a NATO-led mission aimed at stemming the flow of migrants from Libya to Europe could be up and running by July. There are concerns that the number of migrants could soar as the route through Greece and the Balkans remains blocked. Western powers say the political chaos in Libya is being exploited by people smugglers — and they are pressuring rival groups to come together under the new unity government. VOA's Henry Ridgwell reports.
    Video

    Video Russia’s TV Rain Swims Against Tide in Sea of Kremlin Propaganda

    Russia’s media freedoms have been gradually eroded under President Vladimir Putin as his government has increased state ownership, influence, and restrictions on critical reporting. Television, where most Russians get their news, has been the main target and is now almost completely state controlled. But in the Russian capital, TV Rain stands out as an island in a sea of Kremlin propaganda.
    Video

    Video Kurdish Town Receives Refugees but Lacks Resources

    A wave of refugees is pouring into the Kurdish town of Afrin in northern Syria as a result of fighting between rebel forces and Islamic State militants. VOA’s Amina Misto went to the town and reports local authorities are finding it difficult to cope with this influx of internally displaced people. Bronwyn Benito narrates her report.
    Video

    Video Scientists Build Human Tissue on Animal Matrix

    The question has always been, if a gecko can grow back its tail, why can't we regenerate our lost body parts? Well, maybe we can, someday. Scientists are moving towards the ability to rebuild fully functioning organs, and have made significant progress replacing muscles and other tissue.
    Video

    Video Containing Chernobyl Radiation Continues 30 Years After Explosion

    April 26 marks the 30th anniversary of the Chernobyl nuclear disaster. Hundreds were killed following the explosion and it's estimated that thousands more have died from cancers caused by the radiation. Henry Ridgwell traveled to Chernobyl and reports for VOA on the continuing efforts to decommission the site -- and on the fledgling plans for a new future in the vast exclusion zone.
    Video

    Video Frustration Builds Among Refugees Trapped at Macedonian Border

    On the Greek border with Macedonia, 12,000 refugees continue to wait. Since the route to the rest of Europe was closed last month, the makeshift camp at Idomeni has seen protests and tear gas. But while those here wait, their frustration grows — as do reports of people attempting to find new ways of continuing their journey. John Owens reports from Idomeni.
    Video

    Video Researchers: Bees Help Kenyan Farmers Fend Off Elephants

    Elephant crop-raiding continues to be a major source of human-wildlife conflict in Kenya, so one elephant researcher is helping to alleviate the problem near Tsavo East National Park with beehive fences, which use elephants’ natural aversion to bees to deter them from farms. VOA’s Jill Craig visited the area ahead of this month's Giants Club Summit, which will bring together dignitaries at Mount Kenya to find solutions to combat poaching, the No. 1 threat to elephants.

    Special Report

    Adrift The Invisible African Diaspora